CHMG Stock Analysis: Chemung Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 370m USD | 12M Return: 56.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.30M
EPS Trend: 42.0%
Qual. Beats: -1
Rev. Trend: -41.4%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Chemung Financial Corporation (CHMG) is a financial holding company headquartered in Elmira, New York, operating primarily through its subsidiary, Chemung Canal Trust Company. Established in 1833, the institution provides a full suite of retail and commercial banking services, including deposit accounts, residential and commercial mortgages, and consumer lending products such as home equity and automobile loans.
The company operates within the regional banking sub-industry, a sector characterized by a reliance on net interest margin-the difference between interest earned on loans and interest paid on deposits. Beyond traditional lending, Chemung Financial maintains a diversified revenue stream through fiduciary and wealth management services, acting as a custodian and trustee for estate planning, pensions, and profit-sharing trusts.
Regional banks often face unique regulatory and interest rate sensitivities that warrant a deeper look at specific valuation metrics on ValueRay. This business model integrates local market expertise with specialized financial services, including tax preparation and interest rate swaps, to serve small to mid-sized businesses and individual clients across its geographic footprint.
- Net interest margin fluctuates with Federal Reserve monetary policy shifts
- Wealth management and fiduciary fee income stabilizes non-interest revenue
- Asset quality remains sensitive to Upstate New York economic conditions
- Loan portfolio growth depends on commercial and agricultural credit demand
| Net Income: 33.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: -2.45k% < 20% (prev -1.41k%; Δ -1.03k% < -1%) |
| CFO/TA 0.02 > 3% & CFO 47.4m > Net Income 33.5m |
| Net Debt (-157.9m) to EBITDA (55.8m): -2.83 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.83m) vs 12m ago 0.46% < -2% |
| Gross Margin: 44.20% > 18% (prev 60.01%; Δ -15.81% > 0.5%) |
| Asset Turnover: 2.84% > 50% (prev 4.75%; Δ -1.91% > 0%) |
| Interest Coverage Ratio: 1.30 > 6 (EBIT TTM 54.4m / Interest Expense TTM 41.8m) |
| A: -0.70 (Total Current Assets 298.0m - Total Current Liabilities 2.27b) / Total Assets 2.82b |
| B: 0.10 (Retained Earnings 271.2m / Total Assets 2.82b) |
| C: 0.02 (EBIT TTM 54.4m / Avg Total Assets 2.84b) |
| D: 0.11 (Book Value of Equity 270.4m / Total Liabilities 2.55b) |
| Altman-Z'' = -4.03 = D |
As of July 28, 2026, the stock is trading at USD 80.50 with a total of 79,734 shares traded. Over the past week, the price has changed by +4.49%, over one month by +7.91%, over three months by +19.81% and over the past year by +56.86%.
Current recommended Stop Loss: 74.60 (which is 7.3% or 2.1 ATR below the current price).
Chemung Financial has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold CHMG.
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 72.8 | -9.6% |
P/E Trailing = 20.248
P/E Forward = 9.2937
P/S = 3.8789
P/B = 1.4121
Revenue TTM = 80.6m USD
EBIT TTM = 54.4m USD
EBITDA TTM = 55.8m USD
Long Term Debt = 44.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 87.1m USD (from shortLongTermDebt, last fiscal year)
Debt = 140.2m USD (corrected: LT Debt 44.0m + ST Debt 87.1m) + Leases 9.04m
Net Debt = -157.9m USD (calculated: Debt 140.2m - CCE 298.0m)
Enterprise Value = 212.0m USD (369.9m + Debt 140.2m - CCE 298.0m)
Interest Coverage Ratio = 1.30 (Ebit TTM 54.4m / Interest Expense TTM 41.8m)
EV/FCF = 4.62x (Enterprise Value 212.0m / FCF TTM 45.9m)
FCF Yield = 21.63% (FCF TTM 45.9m / Enterprise Value 212.0m)
FCF Margin = 56.90% (FCF TTM 45.9m / Revenue TTM 80.6m)
Net Margin = 41.61% (Net Income TTM 33.5m / Revenue TTM 80.6m)
Gross Margin = 44.20% ((Revenue TTM 80.6m - Cost of Revenue TTM 45.0m) / Revenue TTM)
Gross Margin QoQ = none% (prev 73.43%)
Tobins Q-Ratio = 0.08 (Enterprise Value 212.0m / Total Assets 2.82b)
Interest Expense / Debt = 29.82% (Interest Expense 41.8m / Debt 140.2m)
Taxrate = 24.10% (10.7m / 44.2m)
NOPAT = 41.3m (EBIT 54.4m * (1 - 24.10%))
Current Ratio = 0.13 (Total Current Assets 298.0m / Total Current Liabilities 2.27b)
Debt / Equity = 0.52 (Debt 140.2m / totalStockholderEquity, last quarter 270.4m)
Debt / EBITDA = -2.83 (Net Debt -157.9m / EBITDA 55.8m)
Debt / FCF = -3.44 (Net Debt -157.9m / FCF TTM 45.9m)
Total Stockholder Equity = 258.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.18% (Net Income 33.5m / Total Assets 2.82b)
RoE = 12.98% (Net Income TTM 33.5m / Total Stockholder Equity 258.3m)
RoCE = 18.00% (EBIT 54.4m / Capital Employed (Equity 258.3m + L.T.Debt 44.0m))
RoIC = 7.57% (NOPAT 41.3m / Invested Capital 545.5m)
WACC = 12.11% (E(369.9m)/V(510.0m) * Re(8.12%) + D(140.2m)/V(510.0m) * Rd(29.82%) * (1-Tc(0.24)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 97.81 | Cagr: 0.61%
[DCF] Terminal Value 66.81% ; FCFF base≈37.6m ; Y1≈43.1m ; Y5≈63.4m
[DCF] Fair Price = 151.4 (EV 571.8m - Net Debt -157.9m = Equity 729.7m / Shares 4.82m; r=12.11% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 42.01 | EPS CAGR: 5.62% | SUE: -3.71 | # QB: -1
Revenue Correlation: -41.41 | Revenue CAGR: -7.42% | SUE: -3.44 | # QB: -1
EPS current Quarter (2026-09-30): EPS=1.80 | Chg30d=-3.23% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=7.15 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+23.3% | GrowthRev=+30.2%
EPS next Year (2027-12-31): EPS=7.48 | Chg30d=-0.66% | Revisions=+0% | GrowthEPS=+4.6% | GrowthRev=+7.0%
[Analyst] Revisions Ratio: +17% (up=2, down=1)